Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice.
Triguero A, Cabrera G, Rodríguez M, Soto J, Zamora Y, Pérez M, Wormald MR, Cremata JA. Triguero A, et al. Among authors: zamora y. Plant Biotechnol J. 2011 Dec;9(9):1120-30. doi: 10.1111/j.1467-7652.2011.00638.x. Epub 2011 Aug 7. Plant Biotechnol J. 2011. PMID: 21819534 Free article.
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.
Ávalos I, Lao T, Rodríguez EM, Zamora Y, Rodríguez A, Ramón A, Lemos G, Cabrales A, Bequet-Romero M, Casillas D, Andújar I, Espinosa LA, González LJ, Alvarez Y, Carpio Y, Estrada MP. Ávalos I, et al. Among authors: zamora y. Vaccines (Basel). 2022 Jun 3;10(6):897. doi: 10.3390/vaccines10060897. Vaccines (Basel). 2022. PMID: 35746505 Free PMC article.
Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.
Lao T, Avalos I, Rodríguez EM, Zamora Y, Rodriguez A, Ramón A, Alvarez Y, Cabrales A, Andújar I, González LJ, Puente P, García C, Gómez L, Valdés R, Estrada MP, Carpio Y. Lao T, et al. Among authors: zamora y. PLoS One. 2023 Sep 26;18(9):e0288006. doi: 10.1371/journal.pone.0288006. eCollection 2023. PLoS One. 2023. PMID: 37751460 Free PMC article.
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Garcia JL, Bramante CT, Shah NS, Singh U, Williamson JC, Rebolledo PA, Jagannathan P, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S, Lindsell CJ; Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators. Rothman RL, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2439332. doi: 10.1001/jamanetworkopen.2024.39332. JAMA Netw Open. 2024. PMID: 39422912 Free PMC article. Clinical Trial.
L-PRF in extra-oral wound care.
Pinto N, Yu J, Koirala S, Mourão CF, Andrade C, Rescigno E, Zamora Y, Pinto D, Quirynen M. Pinto N, et al. Among authors: zamora y. Periodontol 2000. 2024 Sep 20. doi: 10.1111/prd.12605. Online ahead of print. Periodontol 2000. 2024. PMID: 39305000 Review.
Toxoplasmosis outbreak in São Paulo, Brazil: Epidemiology and visual outcome.
Finamor LPS, Madalosso G, Levi JE, Zamora YF, Kamioka GA, Marinho P, Nascimento H, Muccioli C, Belfort R Jr. Finamor LPS, et al. Among authors: zamora yf. Arq Bras Oftalmol. 2024 Mar 22;87(3):e20220374. doi: 10.5935/0004-2749.2022-0374. eCollection 2024. Arq Bras Oftalmol. 2024. PMID: 38537044 Free PMC article.
22 results